Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports

By Reuters News

- A deal to combine Johnson & Johnson’s JNJ.N orthopaedics business with Smith & Nephew SN.L to create a $34 billion transatlantic medical technology company unravelled after the London-listed group refused to agree to its former CEO leading the merged business, the Financial Times reported on Friday.

Reuters could not immediately verify the report.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk